FSTSX
Price
$18.06
Change
+$0.09 (+0.50%)
Updated
May 8 closing price
Net Assets
3.73B
LZISX
Price
$8.96
Change
-$0.01 (-0.11%)
Updated
May 8 closing price
Net Assets
9.61M
Ad is loading...

FSTSX vs LZISX

Header iconFSTSX vs LZISX Comparison
Open Charts FSTSX vs LZISXBanner chart's image
Fidelity Series International Sm Cap
Price$18.06
Change+$0.09 (+0.50%)
VolumeN/A
Net Assets3.73B
Lazard International Small Cap Eq Instl
Price$8.96
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets9.61M
FSTSX vs LZISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSTSX vs. LZISX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTSX is a Buy and LZISX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSTSX has more cash in the bank: 3.73B vs. LZISX (9.61M). FSTSX pays higher dividends than LZISX: FSTSX (2.92) vs LZISX (1.70). FSTSX was incepted earlier than LZISX: FSTSX (15 years) vs LZISX (31 years). LZISX (2.14) is less costly to investors than FSTSX (0.02). LZISX is a more actively managed with annual turnover of: 94.00 vs. FSTSX (30.00). FSTSX has a lower initial minimum investment than LZISX: FSTSX (0) vs LZISX (10000). LZISX annual gain was more profitable for investors over the last year : 10.54 vs. FSTSX (6.95). FSTSX return over 5 years is better than : 32.55 vs. LZISX (-1.51).
FSTSXLZISXFSTSX / LZISX
Total Expense Ratio0.021.032%
Annual Report Gross Expense Ratio0.022.141%
Fund Existence15 years31 years-
Gain YTD10.92612.84685%
Front LoadN/AN/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.73B9.61M38,795%
Annual Yield % from dividends2.921.70172%
Returns for 1 year6.9510.5466%
Returns for 3 years24.4711.15219%
Returns for 5 years32.55-1.51-2,151%
Returns for 10 years22.74-9.62-236%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVPX14.43N/A
N/A
Lord Abbett Fundamental Equity P
FTDZX112.10N/A
N/A
Franklin Biotechnology Discovery Adv
PEIQX38.33N/A
N/A
Principal Equity Income R5
NIEYX16.66N/A
N/A
BNY Mellon International Equity Y
WXCIX12.93N/A
N/A
William Blair Emerg Mkts ex China Gr I